TAKEDA PHARMACEUTICAL CO LTD

Holdings History for HilleVax, Inc. - Common Stock (HLVX)

Symbol: HLVX
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Takeda Pharmaceutical Company Limited ownership in HilleVax, Inc. Common Stock (HLVX)

19 Sep 2025 - Takeda Pharmaceutical Company Limited has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of HilleVax, Inc. Common Stock (HLVX). This represents 0% ownership of the company. This is the first filing by TAKEDA PHARMACEUTICAL CO LTD disclosing ownership of HilleVax, Inc. Common Stock (HLVX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Takeda Pharmaceutical Company Limited	0%		$0	0			$2.06	13D/A	17 Sep 2025	19 Sep 2025, 07:22

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-68%	$0	0	-6,724,000	-100%	$2.09	Q3 2025
30 Jun 2025	68%	0%	$13,381,160	6,724,000	0		$1.99	Q2 2025
31 Mar 2025	60%	0%	$9,750,200	6,724,000	0		$1.45	Q1 2025
31 Dec 2024	52%	0%	$13,918,680	6,724,000	0		$2.07	Q4 2024
30 Sep 2024	31%	0%	$11,834,640	6,724,000	0		$1.76	Q3 2024
30 Jun 2024	42%	0%	$97,229,440	6,724,000	0		$14.46	Q2 2024
31 Mar 2024	39%	0%	$111,820,520	6,724,000	0		$16.63	Q1 2024
31 Dec 2023	33%	0%	$107,920,600	6,724,000	0		$16.05	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.